RNASET2 Recombinant antibody
RNASET2 Recombinant Antibody for IF/ICC, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
IF/ICC, ELISA
Conjugate
Unconjugated
CloneNo.
240581H5
Cat no : 83650-3-RR
Synonyms
Validation Data Gallery
Tested Applications
Positive IF/ICC detected in | BxPC-3 cells |
Recommended dilution
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:125-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
The immunogen of 83650-3-RR is RNASET2 Fusion Protein expressed in E. coli.
Tested Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Immunogen | RNASET2 fusion protein Ag28353 相同性解析による交差性が予測される生物種 |
Full Name | ribonuclease T2 |
Calculated molecular weight | 256 aa, 29 kDa |
GenBank accession number | BC039713 |
Gene symbol | RNase T2 |
Gene ID (NCBI) | 8635 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purfication |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
RNASET2(Ribonuclease T2) is also named as RNASE6PL(Ribonuclease 6) and belongs to the RNase T2 family. It is a unique member of the growing family of tumor-antagonizing genes and behaves as a class II tumor suppressor and abolish the tumorigenic potential of an ovarian cancer-derived cell line. This protein has 2 isoforms produced by alternative splicing. Both mildly glycosylated (ranging from38 to 45 kDa) and highly glycosylated forms (ranging from 50 to 80 kDa) of human tumor suppressor protein RNASET2 can be detected in immunoblotting in P. Pastoris(PMID: 21446958).
Protocols
Product Specific Protocols | |
---|---|
IF protocol for RNASET2 antibody 83650-3-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |